home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 27, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

ProteinLinks, Inc.

530 S. Lake Ave #339
Pasadena
United States of America, California

Phone: 626-822-0168
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Founded in 2004, ProteinLinks is a leading proteomics company, headquartered in Pasadena, CA. It is the US provider of yeast two-hybrid screening, with a global customer base comprised of the world's leading universities, government research institutes and pharmaceutical companies in the United States, the United Kingdom, Australia, Canada, France, Denmark, Portugal and Germany. In contrast to our competitors, ProteinLinks performs all screening steps in the United States. Using proprietary technologies, ProteinLinks exploits synergy between a high efficient screening process and an interchangeable modular platform for a wide array of baits (including modified and self-activating baits) and cDNA libraries. Multiple controls throughout the screening process allow scientists to use our data with confidence.

Selected Categories:

Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Contract
- Research
- Services

Last update of this entry: September 30, 2016

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.